908 Devices Raises Revenue Outlook on Strong Q2 Growth

  • 908 Devices reported Q2 2026 revenue of $16.1 million, up 23% YoY.
  • Adjusted EBITDA loss narrowed by more than half to $1.9 million.
  • Raised low end of 2026 revenue guidance to $68.0M-$70.0M (from $67.0M-$70.0M).
  • Shipped over 35 VipIR devices in Q2, including 18 to a South Asia law enforcement agency.
  • Secured a $6 million ProtectIR order from an Asia-Pacific corrections agency post-quarter.

908 Devices is capitalizing on the modernization of law enforcement and safety agencies, with a focus on handheld chemical analysis tools. The company's ability to secure large orders from international customers highlights its growing relevance in global security markets. With a strong cash position and improving margins, 908 Devices appears well-positioned to execute its growth strategy.

Product Adoption Pace
How quickly NIRLab gains traction in the U.S. market after its recent acquisition.
Government Contracts
Whether the momentum with U.S. state and local customers can be sustained.
Operational Efficiency
The pace at which 908 Devices can further narrow its Adjusted EBITDA loss.